Schizophrenia Research
Volume 49, Issue 3 , Pages 261-267 , 30 April 2001

Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone

Received 7 February 2000 ,Accepted 17 April 2000.

References 

  1. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am. J. Psychiatry. 1999;156(11):1686–1696
  2. Allison DB, Fontaine KR, Mentore JL, Cappelleri JC, Chandler LP, Weiden PJ, et al. J. Clin. Psychiatry. 1999;60:215–220
  3. Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S. Olanzapine HGAD study group. Olanzapine versus placebo and haloperidol. Neuropsychopharmacology. 1996;14:111–123
  4. Beasley CM, Hamilton SH, Crawford AM, Dellva MA, Tollefson GD, Tran PV, et al. Olanzapine versus haloperidol: Acute phase results of the international double-blind olanzapine trial. Eur. Neuropsychopharmacology. 1997;7:125–137
  5. Beasley CM, Tollefson GD, Tran PV. Safety of olanzapine. J. Clin. Psychiatry. 1997;58(10):13–17
  6. Bernstein JG. Psychotropic drug induced weight gain: mechanism and management. Clin. Neuropsychopharmacology. 1988;11:S194–S206
  7. Brady KT. Weight gain associated with psychotropic drugs. Southern Med. J. 1989;82:611–617
  8. Casey DE. Side effect profiles of new antipsychotic agents. J. Clin. Psychiatry. 1996;57(11):40–45
  9. Ceskova E, Svestka J. Double-blind comparison of risperidone and haloperidol in schizophrenia and schizoaffective psychoses. Pharmacopsychiatry. 1993;26:121–124
  10. Claus A, Bollen J, de Cuyper H, Eneman M, Malfroid M, Pueskens J, et al. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: A multicenter double-blind comparative study. Acta Psych. Scand. 1992;83:295–305
  11. Daniel DG, Goldberg TE, Weinberger DR, Kleinman JE, Pickar D, Lubick LJ, et al. Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: A pilot study. Am. J. Psychiatry. 1996;153:417–419
  12. Doss FW. The effect of antipsychotic drugs on body weight: A retrospective review. J. Clin. Psychiatry. 1979;40:528–530
  13. Garrattini S, Mennini T, Samanin R. Reduction of food intake by manipulation of central serotonin. Brit. J. Psychiatry. 1989;155(8):S41–S51
  14. Gardos G, Cole JO. Weight reduction in schizophrenics by molindone. Am. J. Psychiatry. 1977;134:302–304
  15. Holden JMC, Holden UP. Weight changes with schizophrenic psychosis and psychotropic drug therapy. Psychosomatics. 1970;9:551–561
  16. Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh: E. & S. Livinstone; 1919;
  17. Leadbetter R, Shutty M, Pavalonis D, Vieweg V, Higgins P, Downs M. Clozapiel-induced weight gain: Prevalence and clinical relevance. Am. J. Psychiatry. 1992;149:68–72
  18. Min SK, Rhee CS, Kim C, Kang DY. Risperidone versus haloperidol in the treatment of chronic schizophrenia patients: A parallel group double-blind comparative trial. Yonsei Med. J. 1993;34:179–196
  19. Nemeroff CB. Dosing the antipsychotic medication olanzapine. J. Clin. Psychiatry. 1997;58(10):45–49
  20. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults. MD: National Institute of Health, National Heart, Lung, and Blood Institute; 1998;
  21. Salomon MS. Histamine: a new factor in control of feeding behavior. Diss. Abstracts. 1992;53(2B):1102
  22. Stanton JM. Weight gain associated with neuroleptic medication: A review. Schizophr. Bull. 1995;21:463–472
  23. Tran PV, Hamilton SH, Kuntz AJ, Potvin JH, Anderson SW, Beasley CM, et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J. Clin. Psychopharmacology. 1997;17:407–418
  24. Umbricht DS, Pollack S, Kane JM. Clozapine and weight gain. J. Clin. Psychiatry. 1994;55(9):157–160
  25. Wetterling T, Mubigbrodt HE. Weight gain: side effect of atypical neuroleptics. J. Clin. Psychopharmacology. 1999;19:316–321
  26. Wirshing DA, Wirshing WC, Kyser L, Berisford MA, Goldstein D, Pashdag J, et al. Novel anti-psychotics: comparison of weight gain liabilities. J. Clin. Psychiatry. 1999;60(6):358–363

PII: S0920-9964(00)00080-3

Schizophrenia Research
Volume 49, Issue 3 , Pages 261-267 , 30 April 2001

Article Tools

* Image Usage & Resolution